Total Payments
$21,460
2024 Payments
$847.53
Companies
43
Transactions
557
Medicare Patients
13,895
Medicare Billing
$1.1M
Payment Breakdown by Category
Consulting$9,500 (44.3%)
Food & Beverage$8,912 (41.5%)
Travel$2,749 (12.8%)
Education$297.93 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,500 | 3 | 44.3% |
| Food and Beverage | $8,912 | 544 | 41.5% |
| Travel and Lodging | $2,749 | 6 | 12.8% |
| Education | $297.93 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NuVasive, Inc. | $11,250 | 5 | $0 (2022) |
| Janssen Biotech, Inc. | $1,638 | 96 | $0 (2024) |
| ABBVIE INC. | $1,432 | 77 | $0 (2024) |
| Globus Medical, Inc. | $1,016 | 5 | $0 (2023) |
| Galderma Laboratories, L.P. | $825.95 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $520.49 | 46 | $0 (2023) |
| MAYNE PHARMA INC. | $464.24 | 29 | $0 (2020) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $392.34 | 28 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $330.45 | 17 | $0 (2023) |
| PFIZER INC. | $254.80 | 17 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $847.53 | 36 | Janssen Biotech, Inc. ($330.41) |
| 2023 | $1,859 | 76 | Janssen Biotech, Inc. ($547.09) |
| 2022 | $12,653 | 68 | NuVasive, Inc. ($11,250) |
| 2021 | $350.63 | 16 | Galderma Laboratories, L.P. ($122.79) |
| 2020 | $384.66 | 22 | Ortho Dermatologics, a division of Bausch Health US, LLC ($70.63) |
| 2019 | $1,976 | 124 | AbbVie, Inc. ($248.46) |
| 2018 | $1,718 | 112 | AbbVie, Inc. ($230.97) |
| 2017 | $1,671 | 103 | Janssen Biotech, Inc. ($284.02) |
All Payment Transactions
557 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.84 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Dermatology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Dermatology | ||||||
| 06/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 06/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: Immunology | ||||||
| 05/13/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Podiatry | ||||||
| 05/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| 04/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $82.43 | General |
| Category: Immunology | ||||||
| 04/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,928 | 13,533 | $1.3M | $303,208 |
| 2022 | 22 | 3,306 | 6,364 | $1.1M | $258,433 |
| 2021 | 26 | 3,540 | 12,555 | $817,643 | $294,730 |
| 2020 | 22 | 3,121 | 5,480 | $666,999 | $219,590 |
Total Patients
13,895
Total Services
37,932
Medicare Billing
$1.1M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,039 | 1,579 | $344,222 | $88,911 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 319 | 423 | $135,360 | $34,378 | 25.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 339 | 427 | $137,067 | $31,440 | 22.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 647 | 874 | $166,934 | $31,423 | 18.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 333 | 380 | $109,060 | $23,639 | 21.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 194 | 194 | $61,498 | $13,292 | 21.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 476 | 2,534 | $43,078 | $11,878 | 27.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 73 | 100 | $44,400 | $11,697 | 26.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 41 | 42 | $37,296 | $8,822 | 23.7% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 17 | 6,400 | $19,200 | $8,299 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $34,293 | $7,885 | 23.0% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 14 | 23 | $17,043 | $4,745 | 27.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 44 | 46 | $16,652 | $3,901 | 23.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 62 | 85 | $13,175 | $3,185 | 24.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 23 | $11,868 | $2,692 | 22.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 36 | 68 | $10,812 | $2,509 | 23.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 26 | 26 | $18,876 | $2,433 | 12.9% |
| 10040 | Acne surgery | Office | 2023 | 24 | 30 | $9,540 | $2,429 | 25.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 23 | 25 | $8,700 | $2,094 | 24.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 14 | $11,634 | $1,494 | 12.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $7,336 | $1,422 | 19.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 14 | $5,922 | $1,301 | 22.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $4,550 | $1,174 | 25.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 31 | $4,092 | $1,065 | 26.0% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 11 | 12 | $3,984 | $1,026 | 25.7% |
About Dr. Rebecca Kelso, M.D
Dr. Rebecca Kelso, M.D is a Dermatology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194876193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Kelso, M.D has received a total of $21,460 in payments from pharmaceutical and medical device companies, with $847.53 received in 2024. These payments were reported across 557 transactions from 43 companies. The most common payment nature is "Consulting Fee" ($9,500).
As a Medicare-enrolled provider, Kelso has provided services to 13,895 Medicare beneficiaries, totaling 37,932 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location San Antonio, TX
- Active Since 01/16/2007
- Last Updated 05/31/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1194876193
Products in Payments
- ALIF (Device) $6,000
- XLIF (Device) $5,250
- TREMFYA (Drug) $1,183
- Humira (Biological) $549.05
- Trauma - Prototype (Device) $522.07
- COSENTYX (Biological) $507.80
- SKYRIZI (Biological) $482.80
- ExcelsiusGPS Robotic Navigation System (Device) $473.30
- DORYX (Drug) $443.90
- BOTOX (Biological) $311.66
- EUCRISA (Drug) $240.63
- ENSTILAR (Drug) $201.73
- STELARA (Biological) $198.42
- EPIDUO FORTE (Drug) $194.33
- Cimzia (Drug) $183.82
- TALTZ (Drug) $151.34
- DUPIXENT (Biological) $150.58
- RINVOQ (Biological) $140.49
- REMICADE (Biological) $140.09
- JUBLIA (Drug) $131.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Antonio
Dr. William Cragun, M.d, M.D
Dermatology — Payments: $1.9M
Dermatology $1.9M
Emily Becker, M.d, M.D
Dermatology — Payments: $937,773
Dermatology $937,773
Dr. Mark Lee, M.d, M.D
Dermatology — Payments: $589,973
Dermatology $589,973
Dr. Lindsey Finklea, M.d, M.D
Dermatology — Payments: $265,879
Dermatology $265,879
Steven Davis, Md, MD
Dermatology — Payments: $114,713
Dermatology $114,713
Stephen Miller, M.d. P.a, M.D. P.A
Dermatology — Payments: $89,896
Dermatology $89,896